WOOFNasdaqRetail-Retail Stores, NECFiscal year ends January 30
Petco Health & Wellness Company, Inc.
Financials through Q2 FY2026, quarter ended Aug 1, 2026Last filing: 10-Q on Sep 4, 2026
$2.34+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $679.76M
- P/E (TTM)
- 23.4
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
38.7%−4.2 pts over 5 years
Operating margin
2.0%−1.9 pts over 5 years
Net margin
0.2%+0.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -2.5% | -0.4% | +3.9% | – | |
| Gross profit | -0.8% | -1.7% | +1.8% | – | |
| Operating income | +1608.0% | -18.9% | -9.1% | – | |
| Net income | – | -53.6% | – | – | |
| EPS, diluted | – | -55.5% | – | – | |
| Free cash flow | +276.3% | +40.1% | +11.4% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 0.8% | |
| Return on assets | – | – | 0.2% | |
| Current ratio | – | 0.89 | 0.90 | |
| Debt to equity | – | 0.80 | 1.28 | |
| Net debt to EBITDA | – | 4.14× | 3.90× | |
| Interest coverage | – | 0.9× | 0.9× | |
| Inventory turnover | – | – | 5.9× | |
| Capex to revenue | – | 3.2% | 2.1% | |
| Diluted shares | – | 0M | 286M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Petco Health & Wellness generated $1.41B from operations and spent $997.82M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$1.41B
Used
$997.82M
Capital expenditure$997.82M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin0.2%
×Asset turnover1.15×
×Equity multiplier4.55×
=Return on equity, FY20250.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 0.2% | 1.15× | 4.55× | 0.8% |
| FY2024 | -1.7% | 1.16× | 4.59× | -8.9% |
| FY2023 | -20.5% | 1.04× | 3.36× | -71.8% |
| FY2022 | 1.5% | 0.92× | 2.82× | 3.9% |
| FY2021 | 2.8% | 0.92× | 2.90× | 7.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
8of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$9.07M
- Cash generatingOperating cash flow above zero$314.05M
- Return on assets improvedROA up on the prior year-1.9% → 0.2%
- Earnings backed by cashOperating cash flow above net income$314.05M vs $9.07M
- Less leverageLong-term debt to assets fell30.4% → 28.8%
- Better liquidityCurrent ratio rose0.85 → 0.90
- No dilutionShare count did not rise273M → 286M
- Gross margin improvedGross margin up on the prior year38.00% → 38.67%
- More efficientAsset turnover rose1.14 → 1.15